European Journal of Cancer
Volume 37, Issue 3 , Pages 369-375, February 2001

Economic analysis of adjuvant therapy with interferon alpha-2a in stage II malignant melanoma

  • A. Lafuma

      Affiliations

    • Cemka, 43 boulevard du Maréchal Joffre, F-92340, Bourg-la-Reine, France
    • Corresponding Author InformationCorresponding author. Tel.: +33-1-4091-3030; fax: +33-1-4091-3031
    • ,
  • B. Dreno

      Affiliations

    • CHR Hôtel-Dieu, Nantes, France
    • ,
  • M. Delaunay

      Affiliations

    • Hôpital Pellegrin, Bordeaux, France
    • ,
  • C. Emery

      Affiliations

    • Cemka, 43 boulevard du Maréchal Joffre, F-92340, Bourg-la-Reine, France
    • ,
  • F. Fagnani

      Affiliations

    • Cemka, 43 boulevard du Maréchal Joffre, F-92340, Bourg-la-Reine, France
    • ,
  • K. Hieke

      Affiliations

    • Roche Pharmaceuticals, Switzerland
    • ,
  • J.-J. Bonerandi

      Affiliations

    • Hôpital Sainte-Marguerite, Marseille, France
    • ,
  • J.-J. Grob

      Affiliations

    • Hôpital Sainte-Marguerite, Marseille, France
    • ,
  • for the French Cooperative Group on Melanoma

      Affiliations

Received 10 April 2000; received in revised form 28 September 2000; accepted 12 November 2000.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(00)00411-1

European Journal of Cancer
Volume 37, Issue 3 , Pages 369-375, February 2001

Article Tools

* Image Usage & Resolution